Onkologie. 2015:9(5):239-241

Treatment of pain in cancer patients, focusing on breakthrough pain

Lukáš Pochop
Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno

Cancer induced chronic pain affects great percentage of oncologic patients. Major subgroup of these patients also suffers from breakthrough

pain which negatively influences their quality of life. Pharmacological or non-pharmacological approaches can be used to treat

cancer pain. Recently we have been using new formula of transmucosal opioids. Their simple usage and quick pain relief represent an

adequate medical form to treat breakthrough pain.

Keywords: cancer pain, breakthrough pain, opioids, fentanyl

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pochop L. Treatment of pain in cancer patients, focusing on breakthrough pain. Onkologie. 2015;9(5):239-241.
Download citation

References

  1. Greco MT, Roberto A, Corli O, Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. See comment in PubMed Commons belowJ Clin Oncol. 2014; 32(36): 4149-4154. Go to original source...
  2. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008; 19(12): 1985-1991. Go to original source...
  3. Dostupné z: http://www.linkos.cz/informace-pro-praxi/modra-kniha/32-farmakoterapie-nadorove-bolesti/.
  4. Adam Z, Krejčí M, Vorlíček J, Obecná onkologie, Praha - Galén 2011: 235-243.
  5. Haugen DF, Hjermstad MJ, Hagen N, Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain. 2010; 149(3): 476-482. Go to original source... Go to PubMed...
  6. Kabelka L, Kozak J, Lejčko J et al. Doporučený postup pro lečbu průlomove nadorove bolesti. Bolest 2011; 14(Suppl 1): 1-5.
  7. Lennernas B, Hedner T, Holmberg M, et al. Pharmacokineticsand tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol 2005; 59(2): 249-253. Go to original source...
  8. Temel JS, Early palliative care for patients with metastatic non-small-cell lung cancer, N Engl J Med. 2010; 363(8): 733-742. Go to original source...
  9. WHO. Cancer pain relief. 2nd ed. Geneva: World Health Organization 1996.
  10. Doulton B, Pharmacologic management of adult breakthrough cancer pain. Can Fam Physician. 2014; 60(12): 1111-1114. Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.